A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Glucagon-like peptide-1 receptor agonist medications for weight loss are significantly transforming the field of facial plastic surgery.

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus ... treat various cancer indications and rheumatoid arthritis.

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...